retatrutide and breastfeeding 🧬 is being called the next generation of weight-loss medication, but it's not a shortcut, it's definitely not for everyone. . ➡️ Unlike standard GLP-1 medications, retatrutide targets three hormone Breastfeeding on GLP-1: Safety &

Researchers studying the impact on pregnant mice , for instance, noted decreases in both fetal body weight and in the activity of various nutrient transporters in the placenta (meaning the fetus wasnt getting the proper amount of vital nutrients)

Moreover, an increasing number of studies have suggested that GLP-1 signaling may serve as a potential drug target for the management of various neurological disorders, including epilepsy and its associated comorbidities (20,25)

JAMA 9 CandeiasE.SebastioI.CardosoS.CarvalhoC.SantosM

References [1] Roche data on file

10 stars

Eohilia, a corticosteroid, is intended for 12 weeks of treatment in patients 11 years and older